Clinical Scenario #3: Applying Biomarkers in Melanoma
This activity will address the increasing use of biomarker testing in the management of patients with melanoma, the factors affecting the selection of the appropriate tests, challenges of interpreting test results and communicating the results to patients, and new developments in biomarker testing.
Category
  • Melanoma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Pharmacy Updates: Updates in the Management of Unresectable or Metastatic Cutaneous Melanoma
Pharmacists play a critical role in patient education, monitoring, and management of treatment-related toxicities and will benefit from a comprehensive review of the novel treatments for cutaneous melanoma.
Category
  • Melanoma
Format
  • Live Webinar
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Event date June 30, 2022
Management of Patients with Advanced Melanoma
Despite recent advancements in immunotherapies and targeted therapies for melanoma patients with late stage disease, treatment options for these patients are not limited to systemic therapies. An overview of current challenges facing this patient population, as well as an in-depth analysis of treatment modalities, will be beneficial to the oncology care team.
Category
  • Melanoma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation